Trader consensus implies an 88.5% probability of no new pandemic in 2026, driven by robust CDC and WHO surveillance revealing no novel pathogen with sustained human-to-human transmission overwhelming global health systems. H5N1 avian influenza continues circulating in wild birds and mammals, but human cases remain sporadic without efficient person-to-person spread, as per CDC's March updates. Clade Ib mpox outbreaks persist regionally without escalating to pandemic levels, and Ethiopia's Marburg event ended in January. Emerging SARS-CoV-2 variant BA.3.2 shows immune escape potential but reflects ongoing evolution, not a fresh threat. Measles surges from vaccine hesitancy are localized epidemics. This stability, bolstered by post-COVID preparedness like the WHO Pandemic Agreement, underpins the odds, though bird flu mutations warrant monitoring ahead of respiratory season peaks.